Prefilled
syringe is a single use syringe filled with parenteral drug. It helps to
exclude various numbers of procedures mandatory for administering a
formulation. The global prefilled syringes market is growing at significant
rate, due to mounting demand for biologics and biosimilars and emergent
injectable drugs pipeline. Different types of syringes contributed to the
market size. The market has witnessed high demand for conventional syringes
over the last few years due to increasing adoption of self-administered
injectable drug.
Download Free Report Sample at: https://www.vynzresearch.com/healthcare/prefilled-syringes-market/request-sample
There
are two materials of syringes, glass and plastic. Glass material is preferred
for manufacturing syringe as the material is non-reactive, and have high
mechanical strength, and tolerability towards heat and transparency. However,
the raised leachability from silicon layer in the presence of biologics is also
transferring the usage of glass to plastic. Of both, plastic prefilled
syringes market witnessed the higher growth worldwide, which is due to
break resistance and decreased surface reactivity.
Moreover,
increasing demand for vaccine, large pool of population base and benefits associated
with syringes are also up surging its demand, as parentral administration is
second most common mode of drug delivery. According to the World Health
Organization (WHO), globally approximately 16 billion injections are
administered every year in developing and transitional countries.
Drug
is delivered with various methods, such as orally, infusion, and injections.
Oral delivery method is the most commonly used drug delivery alternative
globally, as it is cost effective and easy to use for patients. Interaction of
syringe plastic with the drugs and recall of products are the key factor
hindering the global market growth.
Explore Full Report Description at: https://www.vynzresearch.com/healthcare/prefilled-syringes-market
Geographically,
Europe is the largest prefilled syringe market as in the region the prevalence
of chronic disease is increasing. The increasing prevalence of diabetes is a
major concern in Europe. According to International Diabetes Federation (IDF)
in 2015, approximately 59.8 million people were suffering from diabetes in
Europe. In addition, the healthcare expenditure is increasing in Europe, which
has increased the accessibility and affordability of treatment among the
individuals. Growing geriatric population, increasing demand for biosimilars
and biologics and technological advancement of products are also up surging
growth of the European prefilled syringes market.
Key
players in the prefilled syringes industry are catering the demand of these
devices by investing on technologically advanced products in their product
portfolio across the globe. According to Unilife Corporation, a company
involved in the development, design and production of injectable drug delivery
system, approximately 2 billion prefilled syringes are used each year globally.
Becton, Dickinson and Company, Weigao Group, Gerresheimer AG, SCHOTT AG,
Catalent, Inc., West Pharmaceutical Services, Inc., Ompi, Vetter Pharma
International GmbH, Nipro Corporation, and MedPro Inc. are the key players
offering prefilled syringes.
Contact
VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook
No comments:
Post a Comment